Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Manning

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in miceMichael L Manning, Emily Mason-Osann, Masanori Onda, et al.
The Prostate|January 4, 2012
Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluidMichael L Manning, Maya Kostova, Simon A Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2013
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasmaMichael L Manning, Simon A Williams, Christine A Jelinek, et al.
Cellular Signalling|November 28, 2006
Activated stress response pathways within multicellular aggregates utilize an autocrine componentGraham D Jack, M Carla Cabrera, Michael L Manning, et al.
Regulatory Toxicology and Pharmacology : RTP|November 4, 2019
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology productsMichael L Manning, Matthew D Thompson, Haleh Saber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple MyelomaAndrea C Baines, Bindu Kanapuru, Jay Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2019
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young AdultsRuo-Jing Li, Runyan Jin, Chao Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in miceMichael L Manning, Emily Mason-Osann, Masanori Onda, et al.
The Prostate|January 4, 2012
Trypsin-like proteolytic contamination of commercially available psa purified from human seminal fluidMichael L Manning, Maya Kostova, Simon A Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2013
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasmaMichael L Manning, Simon A Williams, Christine A Jelinek, et al.
Cellular Signalling|November 28, 2006
Activated stress response pathways within multicellular aggregates utilize an autocrine componentGraham D Jack, M Carla Cabrera, Michael L Manning, et al.
Regulatory Toxicology and Pharmacology : RTP|November 4, 2019
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology productsMichael L Manning, Matthew D Thompson, Haleh Saber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple MyelomaAndrea C Baines, Bindu Kanapuru, Jay Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2019
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young AdultsRuo-Jing Li, Runyan Jin, Chao Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2018
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid LeukemiaAviva C Krauss, Xin Gao, Liang Li, et al.
Pageof 1